OX40-enhanced tumor rejection and effector T cell differentiation decreases with age

per Ruby, Carl E., Weinberg, Andrew D.
Publicat a J Immunol (2009)

The role of OX40-mediated co-stimulation in T cell activation and survival

per Redmond, William L., Ruby, Carl E., Weinberg, Andrew D.
Publicat 2009

The impact of age on a mitoxantrone-based tumor vaccine

per Stonewall, Keven, Quintero, Cecilia, Zloza, Andrew, Kaufman, Howard, Ruby, Carl
Publicat 2013

Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma

per Kaufman, Howard L, Ruby, Carl E, Hughes, Tasha, Slingluff, Craig L
Publicat 2014

OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in survival

per Vasilevsky, Nicole A., Ruby, Carl E., Hurlin, Peter J., Weinberg, Andrew D.
Publicat 2011

Optimal Management of Metastatic Melanoma: Current Strategies and Future Directions

per Batus, Marta, Waheed, Salman, Ruby, Carl, Petersen, Lindsay, Bines, Steven D., Kaufman, Howard L.
Publicat 2013

Mutations in PIK3CA sensitize breast cancer cells to physiologic levels of aspirin

per Turturro, Sanja B., Najor, Matthew S., Ruby, Carl E., Cobleigh, Melody A., Abukhdeir, Abde M.
Publicat a Breast Cancer Res Treat (2016)

Fasting reduces the incidence of vincristine‐associated adverse events in dogs

per Duckett, Margaret E., Curran, Kaitlin M., Leeper, Haley J., Ruby, Carl E., Bracha, Shay
Publicat a Vet Comp Oncol (2020)

Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging

per Farazi, Michelle, Nguyen, Justine, Goldufsky, Josef, Linnane, Stephanie, Lukaesko, Lisa, Weinberg, Andrew D., Ruby, Carl E.
Publicat 2014

Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells

per Kim, Dae Won, Zloza, Andrew, Broucek, Joseph, Schenkel, Jason M, Ruby, Carl, Samaha, Georges, Kaufman, Howard L
Publicat 2014

Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival

per Broucek, Joseph R, Hughes, Tasha, Huelsmann, Erica J, Poshepny, Joseph L, Ruby, Carl E, Zloza, Andrew, Kaufman, Howard L
Publicat 2013

Pseudomonas aeruginosa exotoxin T induces potent cytotoxicity against a variety of murine and human cancer cell lines

per Goldufsky, Joe, Wood, Stephen, Hajihossainlou, Behnam, Rehman, Tooba, Majdobeh, Omar, Kaufman, Howard L., Ruby, Carl E., Shafikhani, Sasha H.
Publicat a J Med Microbiol (2015)

Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvi...

per Broucek, Joseph, Hughes, Tasha, Huelsmann, Erica, Lusciks, Eugene, Hill , Graham, Zayas, Janet, Poshepny, Joseph, Ruby , Carl, Kohlhapp, Frederick, Zloza, Andrew, Kaufman, Howard
Publicat a J Immunother Cancer (2014)

OX40 Agonists can drive Treg expansion if the cytokine milieu is right

per Ruby, Carl E, Yates, Melissa A, Hirschhorn-Cymerman, Daniel, Chlebeck, Peter, Wolchok, Jedd D, Houghton, Alan N, Offner, Halina, Weinberg, Andrew D
Publicat a J Immunol (2009)

Oncolytic virus therapy for cancer

per Goldufsky, Joe, Sivendran, Shanthi, Harcharik, Sara, Pan, Michael, Bernardo, Sebastian, Stern, Richard H, Friedlander, Philip, Ruby, Carl E, Saenger, Yvonne, Kaufman, Howard L
Publicat a Oncolytic Virother (2013)

Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma

per Weinman, Marcus A., Ramsey, Stephen A., Leeper, Haley J., Brady, Jacqueline V., Schlueter, Andrew, Stanisheuski, Stanislau, Maier, Claudia S., Miller, Tasha, Ruby, Carl E., Bracha, Shay
Publicat a Cancer Cell Int (2021)

Inhibition of p70 S6 Kinase (S6K1) Activity by A77 1726 and Its Effect on Cell Proliferation and Cell Cycle Progress()()

per Doscas, Michelle E., Williamson, Ashley J., Usha, Lydia, Bogachkov, Yedida, Rao, Geetha S., Xiao, Fei, Wang, Yimin, Ruby, Carl, Kaufman, Howard, Zhou, Jingsong, Williams, James W., Li, Yi, Xu, Xiulong
Publicat 2014

A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous Disease...

per Brady, Jacqueline V., Troyer, Ryan M., Ramsey, Stephen A., Leeper, Haley, Yang, Liping, Maier, Claudia S., Goodall, Cheri P., Ruby, Carl E., Albarqi, Hassan A.M., Taratula, Oleh, Bracha, Shay
Publicat a Transl Oncol (2018)

NK cells and CD8+ T cells cooperate to improve therapeutic responses in melanoma treated with interleukin-2 (IL-2) and CTLA-4 blockade

per Kohlhapp, Frederick J, Broucek, Joseph R, Hughes, Tasha, Huelsmann, Erica J, Lusciks, Jevgenijs, Zayas, Janet P, Dolubizno, Hubert, Fleetwood, Vidyaratna A, Grin, Alisa, Hill, Graham E, Poshepny, Joseph L, Nabatiyan, Arman, Ruby, Carl E, Snook, Joshua D, Rudra, Jai S, Schenkel, Jason M, Masopust, David, Zloza, Andrew, Kaufman, Howard L
Publicat a J Immunother Cancer (2015)

Signaling through OX40 Enhances Anti-tumor Immunity

per Jensen, Shawn M., Maston, Levi D., Gough, Michael J., Ruby, Carl E., Redmond, William L., Crittenden, Marka, Li, Yuhuan, Puri, Sachin, Poehlein, Christian H., Morris, Nick, Kovacsovics-Bankowski, Magdalena, Moudgil, Tarsem, Twitty, Chris, Walker, Edwin B., Hu, Hong-Ming, Urba, Walter J., Weinberg, Andrew D., Curti, Brendan D, Fox, Bernard A.
Publicat 2010